| Literature DB >> 25402483 |
Juliana Antero-Jacquemin1, François Deni Desgorces1, Frédéric Dor2, Adrien Sedeaud2, Amal Haïda2, Philippe LeVan3, Jean-François Toussaint4.
Abstract
BACKGROUND/AIM: Strenuous endurance training required to participate in the highest sports level has been associated with deleterious effects on elite athletes' health and cardiac abnormalities. We aimed to describe overall mortality and main causes of deaths of male French rowers participating in at least one Olympic Game (OG) from 1912 to 2012 in comparison with the French general population.Entities:
Mesh:
Year: 2014 PMID: 25402483 PMCID: PMC4234656 DOI: 10.1371/journal.pone.0113362
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1French Olympic rowers by Olympic Games and birth year.
Black diamond represents deceased subjects and blue diamond represents the subjects alive at the study's endpoint. The two periods studied apart are schematically indicated.
French Olympic rowers' cohort description and their overall mortality compared with the French general population.
| Cohort | PT (n = 203) | P1 (n = 30) | P2 (n = 173) |
| Cohort's entry period | 1912–2012 | 1912–1936 | 1948–2012 |
| Nb. of person-years | 6724.2 | 1528.4 | 5195.8 |
| Mean age at cohort's entry in years (SD) | 24.1 (±3.6) | 24.1 (±3.7) | 24.1 (±3.6) |
| Mean follow-up time in years (SD) | 33.8 (±18.5) | 48.4 (±15.7) | 31.0 (±17.7) |
| SMR (95% CI) | 0.58 (0.43–0.78) | 0.63 (0.43–0.89) | 0.40 (0.23–0.65) |
| p-value | <0.001 | 0.009 | <0.001 |
*SMR lower than 1.0, indicates a reduced mortality of rowers compared with the reference population.
Figure 2French Olympic rowers' observed and expected survival curves.
Rowers' observed survival is represented by the solid black curve and its dashed confidence interval. The blue curve refers to the expected survival derived from the matched general French population.
French Olympic rowers' main disease-specific mortality compared with the French general population.
| Main causes of death (n) | Observed/Expected deaths | SMR (95% CI) | p-value |
| Neoplasms (11) | 11/18.4 | 0.59 (0.29–1.07) | 0.09 |
| Cardiovascular diseases (7) | 7/17.0 | 0.41 (0.16–0.84) | 0.01 |
| External causes (6) | 6/5.7 | 1.0 (0.38–2.29) | 0.99 |